Literature DB >> 9669426

Oxygen free radicals and contrast nephropathy.

R E Katholi1, W T Woods, G J Taylor, C L Deitrick, K A Womack, C R Katholi, W P McCann.   

Abstract

Ionic, high-osmolality contrast medium causes nephrotoxicity associated with increased intrarenal adenosine production. To test the hypothesis that oxygen free radicals (produced during intrarenal adenosine catabolism to xanthine) should be implicated in the pathogenesis of ionic, high-osmolality contrast medium nephrotoxicity in humans and to determine whether magnesium protects the kidney from oxygen free radical injury following contrast, 39 patients with mild renal dysfunction were divided into low (LoMg++) and normal (NlMg++) magnesium states and randomized to precoronary angiography oral allopurinol (a xanthine oxidase inhibitor) or placebo. Creatinine clearance and urinary xanthine excretion were measured before and after angiography. Forty-eight hours after contrast medium exposure, placebo-treated LoMg++ and NlMg++ patients had 61%+/-5% and 67%+/-6% increases in urinary xanthine excretion, respectively; however, placebo-treated LoMg++ patients had a greater (79%+/-9% v 35%+/-6%; P < 0.01) decrease in creatinine clearance than placebo-treated NlMg++ patients. Allopurinol-treated LoMg++ and NlMg++ patients had no significant change in urinary xanthine excretion, but did have 40%+/-7% and 33%+/-5% decreases, respectively, in creatinine clearance 48 hours after contrast medium exposure. There was no difference in renal dysfunctional response among placebo-treated NlMg++ patients or allopurinol-treated LoMg++ or NlMg++ patients. These data suggest (1) that oxygen free radicals contribute to ionic, high-osmolality contrast medium nephrotoxicity in hypomagnesemic patients with mild renal disease and (2) that magnesium attenuates the nephrotoxicity mediated by oxygen free radicals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9669426     DOI: 10.1053/ajkd.1998.v32.pm9669426

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  50 in total

1.  Acetazolamide for prevention of contrast-induced nephropathy: a new use for an old drug.

Authors:  Farahnak Assadi
Journal:  Pediatr Cardiol       Date:  2006 Mar-Apr       Impact factor: 1.655

Review 2.  Contrast nephropathy.

Authors:  Shereif H Rezkalla
Journal:  Clin Med Res       Date:  2003-10

Review 3.  Contrast-induced acute kidney injury in interventional cardiology: Emerging evidence and unifying mechanisms of protection by remote ischemic conditioning.

Authors:  Adebayo C Atanda; Oladipupo Olafiranye
Journal:  Cardiovasc Revasc Med       Date:  2017-06-06

4.  Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures.

Authors:  Alper O Onbasili; Yavuz Yeniceriglu; Pinar Agaoglu; Aslihan Karul; Tarkan Tekten; Harun Akar; Guzel Discigil
Journal:  Heart       Date:  2006-10-25       Impact factor: 5.994

5.  Profiling of Kidney Injury Biomarkers in Patients Receiving Cisplatin: Time-dependent Changes in the Absence of Clinical Nephrotoxicity.

Authors:  Melanie S Joy; Lauren M Aleksunes; Blessy George; Xia Wen; Nickie Mercke; Madeleine Gomez; Cindy O'Bryant; Daniel W Bowles; Yichun Hu; Susan L Hogan
Journal:  Clin Pharmacol Ther       Date:  2017-02-14       Impact factor: 6.875

Review 6.  Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.

Authors:  Pál Pacher; Alex Nivorozhkin; Csaba Szabó
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

7.  Potential Role of Allopurinol in Preventing Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Placebo-Controlled Trial.

Authors:  Zahra Ghelich Khan; Azita Hajhossein Talasaz; Hamidreza Pourhosseini; Kianoush Hosseini; Mohammad Javad Alemzadeh Ansari; Arash Jalali
Journal:  Clin Drug Investig       Date:  2017-09       Impact factor: 2.859

8.  Sesame oil prevents acute kidney injury induced by the synergistic action of aminoglycoside and iodinated contrast in rats.

Authors:  Dur-Zong Hsu; Ya-Hui Li; Pei-Yi Chu; Srinivasan Periasamy; Ming-Yie Liu
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

9.  Effect of elective coronary angiography on glomerular filtration rate in patients with advanced chronic kidney disease.

Authors:  Nicola Kumar; Lynn Dahri; Wendy Brown; Neill Duncan; Seema Singh; Christopher Baker; Iqbal Malik; Andrew Palmer; Megan Griffith; Tom Cairns; David Taube
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 8.237

10.  A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trial.

Authors:  Maryam Pakfetrat; Mohammad Hossein Nikoo; Leila Malekmakan; Mahmood Tabandeh; Jamshid Roozbeh; Mahshid Hashemi Nasab; Mohammad Ali Ostovan; Soheila Salari; Mohammad Kafi; Najmeh Moin Vaziri; Farzad Adl; Mehdi Hosseini; Parviz Khajehdehi
Journal:  Int Urol Nephrol       Date:  2009-01-10       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.